Full article: Novel multi-target ligands of dopamine and serotonin

Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment

Molecules, Free Full-Text

Pharmaceuticals, Free Full-Text

Identification and Characterization of ML321: A Novel and Highly Selective D2 Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity

Fluorescent ligands for dopamine D2/D3 receptors

Arylpiperazines as a promising class of multi-target ligands and their SAR.

Pharmaceutics, Free Full-Text

Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease - ScienceDirect

Unraveling the dynamics of dopamine release and its actions on target cells: Trends in Neurosciences

Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence - ScienceDirect

Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands - ScienceDirect